ArticleFrontiers in bioinformatics2026
Integrating trajectory inference and self-explainable predictive models to explore cell state transitions in breast cancer at single-cell resolution.
Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Breast cancer is characterized by a highly heterogeneous cellular environment composed of diverse malignant clones and components of the tumor microenvironment (TME) that collectively influence disease progression. Single-cell RNA sequencing (scRNA-seq) offers a powerful tool to dissect this complexity, enabling high-resolution characterization of tumor heterogeneity and functional interactions within the TME. Moreover, it supports the discovery of clinically relevant subpopulations and potential therapeutic targets. Methods: In this study, we present a novel scRNA-seq dataset from an infiltrating ductal breast cancer, profiling over 5,000 cells and identifying six distinct clusters spanning cancer and TME populations. To explore the molecular drivers of cell state transitions, we integrate pseudotime trajectory inference with interpretable, tree-based machine learning. This combined approach enables the identification of key genes and expression thresholds associated with dynamic phenotypic shifts. Results: Our analysis identified six distinct cellular clusters representing both malignant and TME populations. The integration of pseudotime inference with interpretable machine learning uncovered key genes and specific expression thresholds associated with transcriptional reprogramming and dynamic phenotypic transitions during tumor evolution. Discussion: Unlike black-box models, our framework provides transparent, rule-based insights into transcriptional reprogramming processes underlying tumor progression. The resulting dataset, together with an accessible and transparent analytical pipeline, represents a valuable resource for the breast cancer research community and establishes a foundation for future studies aimed at refining molecular classification and advancing precision therapy development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.